Biotech · Private company
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Track this companyFree. Adds Shaanxi Micot Pharmaceutical Technology Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- MT1002 for InjectionPhase 2 · Acute Coronary SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- MT1002 for injectionPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MT1002 for InjectionPhase 1 · ACS - Acute Coronary SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- MT1013Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Evaluate the Effects of Renal Impairment on the Pharmacokinetics and PharmacodynamicsPHASE1 · TERMINATED · started Apr 15, 2022ClinicalTrials.gov NCT05323136 · fetched Nov 12, 2026
- MT1013 Clinical TRIAL In Healthy SubjectPHASE1 · COMPLETED · started Jun 28, 2021ClinicalTrials.gov NCT04783090 · fetched Nov 12, 2026
- MT1002 Phase II Study in ACS Patients With PCIPHASE2 · TERMINATED · started Dec 2, 2020ClinicalTrials.gov NCT04723186 · fetched Nov 12, 2026
- Single Ascending Dose Trial to Evaluate the Safety, Tolerability, PK, and PD of MT1002 for InjectionPHASE1 · COMPLETED · started Apr 29, 2019ClinicalTrials.gov NCT04116840 · fetched Nov 12, 2026